HL Pharma attended the recent Operationalizing Early Access Programmes Summit. The European event provided an invaluable platform for addressing critical issues within the pharmaceutical industry.
CPHI Barcelona Spain, at the epicentre of the pharmaceutical industry for over three decades and, the 2nd Operationalise Early Access Programmes Europe Summit.
Tick-Borne Encephalitis (TBE) is a viral infection that attacks the central nervous system and can result in serious meningitis, brain inflammation and in some instances death. Travellers who spend...
Hundreds of thousands of Australians with life-threatening high cholesterol could benefit from a new pill in the pipeline, following the successful research and trial by Prof Stephen Nicholls,...
Building on its range of licensed products, HL Pharma is excited announce it now has the exclusive Australian distribution rights for the Carnation® Footcare product range and Carnation® Corn Caps....
The Therapeutic Goods Administration (TGA) has issued 5 infringement notices totalling $13,320 to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only...
HL Pharma is excited to announce Dr Paula Martin has joined the team, partnering on the WomanCare Global obstetric and gynaecological product range.
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the...
A newly approved eye drop hitting the market on Thursday could change the lives of millions of Americans with age-related blurred near vision, a condition affecting mostly people 40 and older.
